Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
3
×
life sciences
national blog main
san francisco blog main
3
×
biotech
clinical trials
europe blog main
fda
national top stories
new york blog main
new york top stories
san francisco top stories
startups
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
black diamond therapeutics
bladder cancer
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
cara therapeutics
community oncology alliance
cvs health
deciphera pharmaceuticals
deerfield management
detroit blog main
detroit top stories
dna sequencing
drew pardoll
What
medicines
3
×
new
3
×
cancer
ipo
activity
aim
approvals
bio
biogen
biotech
black
boost
change
clamped
clinic
community
companies
covid
delays
developing
diagnostics
diamond
docs
drug
economic
eluded
fast
fda
flatiron
helped
hopes
immunotherapy
including
isn’t
lead
leading
lines
lot
molecular
nears
Language
unset
Current search:
medicines
×
cancer
×
" san francisco blog main "
×
new
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care